Literature DB >> 10398469

Reverse Genetics Meets the Nonsegmented Negative-Strand RNA Viruses.

.   

Abstract

Year:  1997        PMID： 10398469     DOI： 10.1002/(sici)1099-1654(199704)7:1<49::aid-rmv181>3.0.co;2-n

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN： 1052-9276            Impact factor:   6.989


× No keyword cloud information.
  9 in total

1.  Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Enhanced measles virus cDNA rescue and gene expression after heat shock.

Authors:  C L Parks; R A Lerch; P Walpita; M S Sidhu; S A Udem
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.

Authors:  Chantal Combredet; Valérie Labrousse; Lucile Mollet; Clarisse Lorin; Frédéric Delebecque; Bruno Hurtrel; Harold McClure; Mark B Feinberg; Michel Brahic; Frédéric Tangy
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  Attenuated measles virus as a vaccine vector.

Authors:  Armando Zuniga; Zili Wang; Matthias Liniger; Lars Hangartner; Michael Caballero; Jovan Pavlovic; Peter Wild; Jean Francois Viret; Reinhard Glueck; Martin A Billeter; Hussein Y Naim
Journal:  Vaccine       Date:  2007-02-02       Impact factor: 3.641

6.  A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

Authors:  Clarisse Lorin; Lucile Mollet; Frédéric Delebecque; Chantal Combredet; Bruno Hurtrel; Pierre Charneau; Michel Brahic; Frédéric Tangy
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine.

Authors:  Richard Stebbings; Michèle Février; Bo Li; Clarisse Lorin; Marguerite Koutsoukos; Edward Mee; Nicola Rose; Joanna Hall; Mark Page; Neil Almond; Gerald Voss; Frédéric Tangy
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 8.  Reverse Genetics for Peste des Petits Ruminants Virus: Current Status and Lessons to Learn from Other Non-segmented Negative-Sense RNA Viruses.

Authors:  Alfred Niyokwishimira; Yongxi Dou; Bang Qian; Prajapati Meera; Zhidong Zhang
Journal:  Virol Sin       Date:  2018-11-19       Impact factor: 4.327

9.  Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses.

Authors:  Matthias Liniger; Armando Zuniga; Azaibi Tamin; Teldja N Azzouz-Morin; Marlyse Knuchel; Rene R Marty; Marian Wiegand; Sara Weibel; David Kelvin; Paul A Rota; Hussein Y Naim
Journal:  Vaccine       Date:  2008-02-22       Impact factor: 3.641
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.